rts logo

Check out this: ReShape Lifesciences Inc (RSLS) could be on the verge of a big rally

ReShape Lifesciences Inc (NASDAQ: RSLS) is -69.51% lower on its value in year-to-date trading and has touched a low of $1.01 and a high of $29.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RSLS stock was last observed hovering at around $1.12 in the last trading session, with the day’s gains setting it 0.24%.

Currently trading at $1.36, the stock is -50.71% and -64.85% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.21 million and changing 21.43% at the moment leaves the stock -82.41% off its SMA200. RSLS registered -85.93% loss for a year compared to 6-month loss of -86.06%..

The stock witnessed a -69.51% gain in the last 1 month and extending the period to 3 months gives it a -73.39%, and is -41.63% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 27.58% over the week and 15.07% over the month.

ReShape Lifesciences Inc (RSLS) has around 31 employees, a market worth around $0.99M and $8.18M in sales. Profit margin for the company is -86.36%. Distance from 52-week low is 34.65% and -95.31% from its 52-week high. The company has generated returns on investments over the last 12 months (-451.85%).

.

ReShape Lifesciences Inc (RSLS) Top Institutional Holders

The shares outstanding are 0.70M, and float is at 0.69M with Short Float at 3.27%.

ReShape Lifesciences Inc (RSLS) Insider Activity

The most recent transaction is an insider sale by STANKOVICH THOMAS , the company’s Chief Financial Officer. SEC filings show that STANKOVICH THOMAS sold 48 shares of the company’s common stock on May 31 ’24 at a price of $0.25 per share for a total of $12.0. Following the sale, the insider now owns 22777.0 shares.

ReShape Lifesciences Inc disclosed in a document filed with the SEC on Feb 29 ’24 that STANKOVICH THOMAS (Chief Financial Officer) sold a total of 43 shares of the company’s common stock. The trade occurred on Feb 29 ’24 and was made at $0.17 per share for $7.0. Following the transaction, the insider now directly holds 22825.0 shares of the RSLS stock.

Related Posts